Managing Fluoxetine Intolerance While Starting Bupropion SR
If a patient cannot tolerate higher fluoxetine doses while initiating bupropion SR 150 mg twice daily, reduce the fluoxetine dose to the lowest effective level (or discontinue it) while maintaining bupropion at 150 mg once daily initially, then titrate bupropion slowly to the target dose of 150 mg twice daily as tolerated.
Dosing Strategy
Bupropion Titration Approach
The FDA-approved dosing for bupropion SR emphasizes gradual titration to minimize adverse effects 1:
- Days 1-3: Start bupropion SR 150 mg once daily in the morning
- Day 4 onward: Increase to 150 mg twice daily (300 mg/day total) only if the initial dose is tolerated
- Maximum dose: 300 mg per day (150 mg twice daily)
Critical timing consideration: Give the second dose before 3 PM to minimize insomnia risk 2.
Fluoxetine Dose Reduction
When fluoxetine is not tolerated at higher doses:
- Reduce fluoxetine to 10 mg every other morning or even lower doses 2
- Consider that fluoxetine has a very long half-life, so side effects may persist for weeks even after dose reduction 3
- Alternative: Discontinue fluoxetine entirely and rely on bupropion monotherapy, given that switching strategies show similar efficacy to augmentation strategies 4
Evidence for Combination vs. Switching
Combination Therapy Data
Research supports combining bupropion with SSRIs when tolerated. In a study of 27 patients with partial SSRI response, 70% showed greater symptomatic improvement when bupropion (mean 243 mg/day) was combined with an SSRI (mean 31 mg fluoxetine-equivalents) compared to monotherapy 5. However, this involved lower SSRI doses than typical monotherapy.
Another study found that combining bupropion SR 150 mg/day with fluoxetine 20 mg/day was well-tolerated, with no significant pharmacokinetic interactions between these two drugs 6. Sexual dysfunction improved significantly with combination therapy.
Switching Strategy
If fluoxetine intolerance persists despite dose reduction, switching to bupropion monotherapy is a viable alternative. A study of 29 patients with fluoxetine-resistant depression found that switching to bupropion SR resulted in 35% full responders and 25% partial responders 7. The STAR*D trial demonstrated similar efficacy between various switch strategies, including switching to bupropion SR 4.
Managing Tolerability Issues
Common Pitfalls to Avoid
Rapid titration: Starting bupropion at 300 mg/day or increasing too quickly significantly increases discontinuation rates. Studies show DCAE (discontinuation due to adverse events) of 15% with rapid titration vs. 3.6% with slow titration 8
Maintaining high fluoxetine doses: The evidence suggests lower SSRI doses are better tolerated in combination therapy. The successful combination studies used fluoxetine-equivalent doses around 30 mg/day, not the typical 40-60 mg monotherapy doses 5
Ignoring timing: Bupropion's activating properties require morning dosing, with the second dose before 3 PM 2
Monitoring for Adverse Effects
Watch for these specific issues:
- Anxiety/agitation: Bupropion can initially worsen anxiety 3. If this occurs, maintain the lower dose longer or reduce fluoxetine further
- Insomnia: Common with bupropion (22% incidence) 2. Adjust timing of second dose or reduce evening fluoxetine dose
- Seizure risk: Maximum 300 mg/day bupropion; contraindicated with seizure history 9
- Serotonin syndrome risk: Though rare with this combination, monitor for mental status changes, neuromuscular hyperactivity, and autonomic instability when combining serotonergic agents 3
Practical Algorithm
Step 1: Reduce fluoxetine to 10-20 mg/day (or discontinue if poorly tolerated)
Step 2: Start bupropion SR 150 mg once daily in the morning
Step 3: After 3-7 days, if tolerated, increase to 150 mg twice daily (second dose before 3 PM)
Step 4: Reassess at 2 weeks:
- If improved and tolerated: Continue combination at these doses
- If fluoxetine still not tolerated: Taper off fluoxetine over 10-14 days and continue bupropion monotherapy 1
- If bupropion not tolerated: Consider switching to a different antidepressant class entirely
Step 5: Allow 4-8 weeks total for full therapeutic assessment 2
Key Contraindications
Bupropion is contraindicated in patients with 9:
- Seizure disorders or conditions increasing seizure risk (including eating disorders)
- Current or prior diagnosis of bulimia or anorexia nervosa
- Abrupt discontinuation of alcohol, benzodiazepines, or barbiturates
- Use of MAO inhibitors within 14 days
- Closed-angle glaucoma